
Emtricitabine 200 mg and tenofovir alafenamide 25 mg tablets, F/TAF (Descovy, Gilead) was just as effective as emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg F/TDF (Truvada).

Emtricitabine 200 mg and tenofovir alafenamide 25 mg tablets, F/TAF (Descovy, Gilead) was just as effective as emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg F/TDF (Truvada).

Remdesivir is not approved by the FDA. However, EUA allows for distribution and emergency use for treatment of COVID-19.

A new collaboration agreement was made between Moderna, Inc, and Lonza Ltd, to manufacture Moderna’s mRNA vaccine against the coronavirus disease 2019.

If the majority of Americans were diagnosed with COVID-19, the total cost of hospitalizations, ventilators, and other resources could cost $654 billion.

Today, we’re thanking Shady Zarnegin, PharmD, lead pharmacist at a Rite Aid in Los Angeles, California.

The relief money will be distributed on the basis of operating expenses.

There are few effective treatment options for patients with HER2-positive breast cancer who have received 2 or more previous therapies for advanced disease, according to the study authors.

The FDA has granted Bio-Rad Laboratories Emergency Use Authorization for the company’s SARS-CoV-2 Total Ab test.

A randomized clinical trial offers strong evidence that a combination of 2 targeted melanoma drugs when given continuously keeps cancer from growing or spreading longer compared with intermittent treatment.

Engaging in discussions with patients at high risk of complications from COVID-19 without seeming patronizing is an important skill that many pharmacists should practice.

Where did Charles R. Walgreen Sr used to work before he got his start in the pharmacy field?

The results of the ongoing trial were presented at the 2020 American Association for Cancer Research Virtual Annual Meeting I.

Government officials have said it may be possible to reduce the United States’ dependence on other countries, but that it would be extremely complicated and difficult.

Survey finds pharmacists are mostly content with their compensation, but only moderately happy with their jobs

Previously, the only women with ovarian cancer eligible to be treated with PARP inhibitors as monotherapy in the maintenance setting were those with a BRCA mutation.

Pharmacy managers can promote a culture of safety that helps to reduce medication errors.

Today, we’re celebrating the work of Andrea Cumberbatch, CPhT, at Costco Pharmacy in New Rochelle, New York.

The STRIP examined the benefits of promoting cardiovascular health by dietary counseling from infancy to early adulthood.

According to new research, biomarkers that signal whether a patient's cancer treatment may be harming their heart have been identified.

Insights from within both the retail and health system pharmacy environments related to the expanded scope of practice.

Researchers have discovered a natural protective mechanism that leads to the programmed death of potentially diseased cancer cells.

New research on the structure of HIV has revealed a promising novel drug target for treating HIV infection.

Several national pharmacy chains are preparing to roll out testing for COVID-19 in the coming weeks, including Health Mart, Kroger Co, and other chain pharmacies.

The Caring for Each Other initiative will include a Sesame Street video that features the Muppets thanking “Super Families.”

The COVID-19 pandemic shows that pharmacists can serve as nationally recognized providers and can contribute greatly to policy as it pertains to disease management, outbreaks, and workplace safety.

The 7 hardest-hit states all have mortality rates between 113% and 172% higher than normal, while New York City’s death rate is 325% higher than usual.

Efinaconazole was first approved by the FDA in June 2014 for patients 18 and older.

Remdesivir is not approved by the FDA nor licensed or approved anywhere in the world.

Today, we’re celebrating Carrie James, PharmD, at King’s Daughters’ Health Hospital in Madison, Indiana.

Research confirms earlier studies that found talazoparib improved patient-reported quality-of-life measures and had a tolerable safety profile.